You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Clinical Trial Search Results

Baystate has clinical trials in several medical specialties. Clinical trials can help our patients by making advanced care available to them right in their communities.

Is volunteering for a clinical trial right for you? Learn more.

Page 1 of 1 | Results 1 - 5 of 5

A comparison of fractional flow reserve vs. coronary (heart) Angiography for coronary multivessel evaluation

The purpose of this study is to demonstrate that Fractional Flow Reserve (FFR)-guided Percutaneous Coronary Intervention (PCI) is non-inferior to coronary artery bypass graft surgery (CABG) in patients with multi-vessel Coronary Artery Disease (CAD). FFF-guided PCI might result in lower rates of death, heart attack, and the need for repeat revascularization as compared to what was seen after CABG surgery. There is also the possibility of a chance at a shorter recovery time with the minimally invasive FFR-guided PCI versus CABG surgery.
Dr. Amir Lotfi
Heart

Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199

Recruiting

Coronary Artery Lesions

Gregory Giugliano, MD
Heart

Baystate Medical Center, 759 Chestnut Street, Springfield, MA

Recruiting

Physiologic Assessment of Coronary Stenosis Following PCI (Percutaneous coronary intervention)

Amir Lotfi, MD
Heart

Davis Family Heart & Vascular Center
Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199

Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair using the Nellix® System

The objective of this study is to assess the safety and effectiveness of the Endologix® EndoVascular Aneurysm Sealing System for the repair of abdominal aortic aneurysms (AAA).
Neal Hadro, MD
Heart

Baystate Medical Center
759 Chestnut St.
Springfield, MA 01199

Transcatheter Aortic Valve Replacement in Low Risk Patients

The purpose of this study is to demonstrate that the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement (TAVR) system as measured by rates of all-cause mortality or disabling stroke at two years is non-inferior to Surgical Aortic Valve Replacement (SAVR) in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.

Dr. Ashequl Islam
Heart

Baystate Medical Center
759 Chestnut Street
Springfield, MA 01199

Recruiting
Page 1 of 1 | Results 1 - 5 of 5